Including Sovaldi's $84,000 price, adaptive licence pilots from the EMA and is 2015 a turning point ...
Our quarterly newsletter shares our perspectives on the latest news, developments and thinking withi...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
